Concepedia

Jeremy Barton

JB

Statistics

Publications

23

Citations

2.7K

H-Index

18

Active since

1986

Affiliations

Northwestern University(Current)

Seagen (United States)

The University of Texas MD Anderson Cancer Center

Tennessee Oncology

Dana-Farber Cancer Institute

Jeremy Barton is an author at Northwestern University specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

1986–2019

23

Publications

23

The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients

Jill Hallin, Lars D. Engstrom, Lauren Hargis et al. · Cancer Discovery · 2019 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +17

Large-Area Nanoscale Patterning: Chemistry Meets Fabrication

Joel Henzie, Jeremy Barton, Christopher L. Stender et al. · Accounts of Chemical Research · 2006 · 212 citations

Engineering, Materials Engineering, Materials Science +16

A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies

Nancy L. Bartlett, Anas Younes, Matthew Carabasi et al. · Blood · 2007 · 196 citations · Full text

Medicine, Hematology, Oncology +8

Tetrahedral Zinc Blende Tin Sulfide Nano‐ and Microcrystals

Eric C. Greyson, Jeremy Barton, Teri W. Odom · Small · 2006 · 194 citations · Full text

Natural Sciences, Chemistry, Materials Science +17

A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer

Katherine M. Bell‐McGuinn, Carolyn M. Matthews, Steffan N. Ho et al. · Gynecologic Oncology · 2011 · 168 citations

Medicine, Oncology, Pharmacotherapy +17

1–5 of 23